Fig. 1 · Structure

Documents & Downloads

Anguizole

Cat. No. A11294 CAS 442666-98-0

HCV replication Inhibitor

Anguizole is a small molecule inhibits HCV replication and alters NS4B's subcellular distribution.

In Stock

Publications for Anguizole

1 publication citing this product

  1. Choi M, .et al. , Virus Genes., 2013, Dec;47(3):395-407 PMID: 23868571

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Bioactivity / Mechanism

Anguizole inhibited NS4B AH2 peptide-associated lipid-vesicle aggregation in a cell-free assay. This functional result supports interference with an NS4B-related membrane process but does not establish a binding affinity. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cellular Effect

Cell Line Activity Value Description Reference
Huh-7 CC50 > 50 μM Cytotoxicity against human HuH7 cells infected with HCV genotype 1b after 48 hrs by WST-1 assay [PMID: 26241789]
Huh-7 EC50 0.31 μM Antiviral activity against HCV genotype 1b infected in Huh7 cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter-based viral replicon assay [PMID: 26241789]
Huh-7 EC50 0.56 μM Antiviral activity against HCV genotype 1a infected in Huh7 cells assessed as inhibition of viral replication after 48 hrs by luciferase reporter-based viral replicon assay [PMID: 26241789]
Huh-7 EC50 0.63 μM Antiviral activity against HCV infected in human HuH7 cells assessed as inhibition of viral replication after 72 hrs by ELISA-based viral replicon assay [PMID: 26241789]
Huh-7 EC50 450 nM Antiviral activity against wild type HCV genotype 1b infected in human HuH7 cells after 48 hrs by luciferase reporter gene assay [PMID: 24900511]
Huh-7 EC50 740 nM Antiviral activity against wild type HCV genotype 1a infected in human HuH7 cells after 48 hrs by luciferase reporter gene assay [PMID: 24900511]
Sf9 IC50 22 nM Displacement of [3H]-3-(1-(3-chloro-6-isopropyl-8-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carbonyl)piperidin-4-yl)oxazolidin-2-one from HCV genotype 1b His6-tagged NS4B expressed in baculovirus infected Sf9 cells after overnight incubation [PMID: 24900511]

Anguizole Research Summary

This section summarizes 2 in vitro studies of Anguizole from 1 published reference. In vitro models include synthetic NS4B AH2 peptide with POPC lipid vesicles.

Anguizole In Vitro Studies

Anguizole inhibited HCV replicon activity with reported mean EC50 values of 310 nM (genotype 1b) and 560 nM (1a). Genotype 2a was substantially less responsive (EC50 > 50 µM); the reported cellular CC50 was > 50 µM. These are cell-assay endpoints. [1]

Genotype-dependent activity in HCV replicon cells

Cell-based study · HCV luciferase-linked replicons: genotypes 1b, 1a and 2a; stable genotype 1b ET cells derived from Huh7 [1]

Activity differed by genotype. WST-1 cytotoxicity was measured alongside replication; it is not a clinical safety endpoint.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Genotype 1b replicationmean EC50 310 nM[1]
Genotype 1a replicationmean EC50 560 nM[1]
Genotype 2a replicationEC50 > 50 µM[1]
Cellular cytotoxicitymean CC50 > 50 µM[1]

Literature-Reported Treatment Conditions

Exposure duration
48 h for the stable genotype 1b assay (§2.4)
Method
Compound exposure; reporter response compared with no-compound control.
Vehicle
DMSO; final percentage not specified for the stable assay
Reported limits
Genotype 1a/2a protocol details are not separately specified in the reviewed assay section. Figure 1B illustrates a different concentration range from §2.4; no unified range assigned.
Methods and source locations

Compound reported in the paper: Anguizole; Compound label in the paper: Chemical Block A2828/0119446

Compound-level evidence; no validation of an Adooq lot.

§2.2; §2.4; §3.1; Figure 1A–B and caption

Genotype 1b replication: Luciferase reporter — §3.1; Figure 1B and caption

Genotype 1a replication: Luciferase reporter — §3.1

Genotype 2a replication: Luciferase reporter; highest concentration tested — §3.1

Cellular cytotoxicity: WST-1 — §3.1; Figure 1 caption

Cell-free inhibition of AH2-associated vesicle aggregation

Biochemical assay · Synthetic NS4B AH2 peptide with POPC lipid vesicles [1]

Anguizole reduced peptide-associated vesicle aggregation; clemizole hydrochloride did not significantly inhibit this endpoint. This is a functional assay, not a binding-affinity determination.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Mean effective vesicle diameterDLS diameter POPC alone: 88 nm; POPC + AH2: 5377 nm; POPC + AH2 + anguizole: 126 nm[1]

Literature-Reported Treatment Conditions

Treatment concentration
26 µM anguizole; 13 µM AH2 peptide; 300 µM POPC
Method
Cell-free DLS at 25 °C
Reported limits
Incubation duration and final vehicle for DLS not specified in reviewed §2.7/caption.
Methods and source locations

Compound reported in the paper: Anguizole; Compound label in the paper: Chemical Block A2828/0119446

Compound-level evidence; no validation of an Adooq lot.

§2.2; §2.7; §3.5; Figure 6 and caption

Mean effective vesicle diameter: Dynamic light scattering; at least 3 independent experiments; SEM in Figure 6E — §3.5; Figure 6A–E and caption

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 442666-98-0
Applications HCV replication Inhibitor
Formula C17H11ClF2N4O2S
Molecular Weight 408.8
SMILES
C1=COC(=C1)C2=NC3=CC(=NN3C(=C2)C(F)(F)Cl)C(=O)NCC4=CC=CS4

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Anguizole Research References

  1. [1] Paul D Bryson, Nam-Joon Cho, Shirit Einav, et al. A small molecule inhibits HCV replication and alters NS4B’s subcellular distribution Antiviral Research (2010). PMID: 20363257 DOI: 10.1016/j.antiviral.2010.03.013 Source material

Publications

1 publication citing this product

  1. Choi M, .et al. , Virus Genes., 2013, Dec;47(3):395-407 PMID: 23868571

Added to your cart

View Cart Checkout
Loading...